Source: BioPharma-Reporter

Amarex Clinical Research: CytoDyn scores $12M in legal battle win: A huge breakthrough for its antibody drug trials

Amid a period of clinical holds and legal tangles, the US antibody specialist CytoDyn has reached a settlement to resolve legal disputes with its former contract research organization (CRO) Amarex Clinical Research.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kazem Kazempour's photo - President & CEO of Amarex Clinical Research

President & CEO

Kazem Kazempour

CEO Approval Rating

69/100

Read more